Accessibility navigation

Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service

Donyai, P. and Van den Berg, M. (2009) Coronary heart disease risk screening: the community pharmacy Healthy Heart Assessment Service. Pharmacy World & Science, 31 (6). pp. 643-647. ISSN 0928-1231

Full text not archived in this repository.

To link to this item DOI: 10.1007/s11096-009-9338-4


Objectives We examined the characteristics and CHD risks of people who accessed the free Healthy Heart Assessment (HHA) service operated by a large UK pharmacy chain from August 2004 to April 2006. Methods Associations between participants’ gender, age, and socioeconomics were explored in relation to calculated 10-year CHD risks by cross-tabulation of the data. Specific associations were tested by forming contingency tables and using Pearson chi-square (χ2). Results Data from 8,287 records were analysable; 5,377 were at low and 2,910 at moderate-to-high CHD risk. The likelihood of moderate-to-high risk for a male versus female participant was significantly higher with a relative risk ratio (RRR) 1.72 (P < 0.001). A higher percentage of those in socioeconomic categories ‘constrained by circumstances’ (RRR 1.15; P < 0.05) and ‘blue collar communities’ (RRR 1.13; P < 0.05) were assessed with moderate-to-high risk compared to those in ‘prospering suburbs’. Conclusions People from ‘hard-to-reach’ sectors of the population, men and people from less advantaged communities, accessed the HHA service and were more likely to return moderate-to-high CHD risk. Pharmacists prioritised provision of lifestyle information above the sale of a product. Our study supports the notion that pharmacies can serve as suitable environments for the delivery of similar screening services.

Item Type:Article
Divisions:Faculty of Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmacy Practice Research Group
ID Code:5922
Uncontrolled Keywords:Cardiovascular disease Community pharmacy services Counselling Directive counselling Health promotion Lipid modifying agents Risk factors United Kingdom
Publisher:Springer Netherlands

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation